168 related articles for article (PubMed ID: 38644081)
1. Influence of MAFLD and NAFLD on arterial stiffness: A longitudinal cohort study.
Yoo TK; Lee SW; Lee MY; Choi H; Sung KC
Nutr Metab Cardiovasc Dis; 2024 Jul; 34(7):1769-1778. PubMed ID: 38644081
[TBL] [Abstract][Full Text] [Related]
2. New definition of metabolic dysfunction-associated fatty liver disease with elevated brachial-ankle pulse wave velocity and albuminuria: a prospective cohort study.
Wang J; Liu S; Cao Q; Wu S; Niu J; Zheng R; Bie L; Xin Z; Zhu Y; Wang S; Lin H; Wang T; Xu M; Lu J; Chen Y; Xu Y; Wang W; Ning G; Xu Y; Li M; Bi Y; Zhao Z
Front Med; 2022 Oct; 16(5):714-722. PubMed ID: 35507246
[TBL] [Abstract][Full Text] [Related]
3. Association between non-alcoholic fatty liver disease and arterial stiffness in the non-obese, non-hypertensive, and non-diabetic young and middle-aged Chinese population.
Yu XY; Zhao Y; Song XX; Song ZY
J Zhejiang Univ Sci B; 2014 Oct; 15(10):879-87. PubMed ID: 25294377
[TBL] [Abstract][Full Text] [Related]
4. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY
World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084
[TBL] [Abstract][Full Text] [Related]
5. Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study.
Sung KC; Yoo TK; Lee MY; Byrne CD; Zheng MH; Targher G
Arterioscler Thromb Vasc Biol; 2023 Mar; 43(3):482-491. PubMed ID: 36727522
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty liver disease is associated with progression of arterial stiffness.
Li N; Zhang GW; Zhang JR; Jin D; Li Y; Liu T; Wang RT
Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):218-23. PubMed ID: 25456154
[TBL] [Abstract][Full Text] [Related]
7. Transition patterns of metabolic dysfunction-associated fatty liver disease status in relation to arterial stiffness progression: a health check-up cohort study.
Liu L; Wang C; Deng S; Yuan T; Zhu X; Deng Y; Qin Y; Wang Y; Yang P
Sci Rep; 2023 Jun; 13(1):9690. PubMed ID: 37322025
[TBL] [Abstract][Full Text] [Related]
8. The association between nonalcoholic fatty liver disease, metabolic syndrome and arterial stiffness in nondiabetic, nonhypertensive individuals.
Kim BJ; Kim NH; Kim BS; Kang JH
Cardiology; 2012; 123(1):54-61. PubMed ID: 22986520
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease without overlapping metabolic-associated fatty liver disease and the risk of incident type 2 diabetes.
Cho Y; Chang Y; Ryu S; Wild SH; Byrne CD
Liver Int; 2023 Nov; 43(11):2445-2454. PubMed ID: 37387519
[TBL] [Abstract][Full Text] [Related]
10. Arterial Stiffness Preceding Diabetes: A Longitudinal Study.
Zheng M; Zhang X; Chen S; Song Y; Zhao Q; Gao X; Wu S
Circ Res; 2020 Dec; 127(12):1491-1498. PubMed ID: 32985370
[TBL] [Abstract][Full Text] [Related]
11. Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study.
Jung CY; Koh HB; Park KH; Joo YS; Kim HW; Ahn SH; Park JT; Kim SU
Diabetes Metab; 2022 Jul; 48(4):101344. PubMed ID: 35346856
[TBL] [Abstract][Full Text] [Related]
12. Leptin/adiponectin ratio correlates with hepatic steatosis but not arterial stiffness in nonalcoholic fatty liver disease in Japanese population.
Mikami K; Endo T; Sawada N; Igarashi G; Kimura M; Hasegawa T; Iino C; Tomita H; Sawada K; Nakaji S; Matsuzaka M; Torok NJ; Fukuda S
Cytokine; 2020 Feb; 126():154927. PubMed ID: 31756645
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of controlled attenuation parameter and liver stiffness measurement for detecting increased arterial stiffness in asymptomatic populations in China.
Yu XY; Song XX; Tong YL; Wu LY; Song ZY
Medicine (Baltimore); 2020 Nov; 99(48):e23360. PubMed ID: 33235107
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
Wang X; Wu S; Yuan X; Chen S; Fu Q; Sun Y; Lan Y; Hu S; Wang Y; Lu Y; Qu S; Wang L
J Clin Endocrinol Metab; 2022 Jan; 107(2):e745-e755. PubMed ID: 34467980
[TBL] [Abstract][Full Text] [Related]
15. Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China.
Liang Y; Chen H; Liu Y; Hou X; Wei L; Bao Y; Yang C; Zong G; Wu J; Jia W
J Clin Endocrinol Metab; 2022 Jan; 107(1):88-97. PubMed ID: 34508601
[TBL] [Abstract][Full Text] [Related]
16. The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis.
Liu S; Wang J; Wu S; Niu J; Zheng R; Bie L; Xin Z; Wang S; Lin H; Zhao Z; Wang T; Xu M; Lu J; Chen Y; Xu Y; Wang W; Ning G; Bi Y; Li M; Xu Y
Metabolism; 2021 Jul; 120():154779. PubMed ID: 33895182
[TBL] [Abstract][Full Text] [Related]
17. The relationship between arterial stiffness and nonalcoholic fatty liver disease.
Lee YJ; Shim JY; Moon BS; Shin YH; Jung DH; Lee JH; Lee HR
Dig Dis Sci; 2012 Jan; 57(1):196-203. PubMed ID: 21750929
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease.
Arai T; Atsukawa M; Tsubota A; Kawano T; Koeda M; Yoshida Y; Tanabe T; Okubo T; Hayama K; Iwashita A; Itokawa N; Kondo C; Kaneko K; Kawamoto C; Hatori T; Emoto N; Iio E; Tanaka Y; Iwakiri K
PLoS One; 2019; 14(11):e0224184. PubMed ID: 31721770
[TBL] [Abstract][Full Text] [Related]
19. Increased whole blood viscosity associated with arterial stiffness in patients with non-alcoholic fatty liver disease.
Yu KJ; Zhang MJ; Li Y; Wang RT
J Gastroenterol Hepatol; 2014 Mar; 29(3):540-4. PubMed ID: 23981121
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic Fatty Liver Disease Without Metabolic-associated Fatty Liver Disease and the Risk of Metabolic Syndrome.
Sinn DH; Kang D; Choi SC; Hong YS; Zhao D; Guallar E; Park Y; Cho J; Gwak GY
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1873-1880.e1. PubMed ID: 36152895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
